NEOMAB Trademark

Trademark Overview

On Thursday, February 22, 2024, a trademark application was filed for NEOMAB with the United States Patent and Trademark Office. The USPTO has given the NEOMAB trademark a serial number of 98417072. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, February 22, 2024. This trademark is owned by GemPharmatech Co., Ltd.. The NEOMAB trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biological research; Chemical research; Conducting of feasibility studies in the field of new technologies; Culturing of cells for others for scientific research purposes; Medical research; Research and development of new products for others; Research in the field of gene editing technology; Scientific laboratory services; Scientific research; Scientific research in the field of genetics
neomab

General Information

Serial Number98417072
Word MarkNEOMAB
Filing DateThursday, February 22, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, February 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkNEO MAB
Translation of Words in MarkThe wording "NeoMab" has no meaning in a foreign language.
Goods and ServicesBiological research; Chemical research; Conducting of feasibility studies in the field of new technologies; Culturing of cells for others for scientific research purposes; Medical research; Research and development of new products for others; Research in the field of gene editing technology; Scientific laboratory services; Scientific research; Scientific research in the field of genetics

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 22, 2024
Primary Code042
First Use Anywhere DateMonday, August 21, 2023
First Use In Commerce DateMonday, August 21, 2023

Trademark Owner History

Party NameGemPharmatech Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNanjing, Jiangsu 210000
CN

Trademark Events

Event DateEvent Description
Saturday, June 29, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 22, 2024NEW APPLICATION ENTERED

Related Keywords

neomab research scientific field others gene products development editing technology genetics